Clemson University

TigerPrints
Publications

Mechanical Engineering

1-2022

Tunable Blood Shunt for Neonates With Complex Congenital
Heart Defects
Ellen Garver
Christopher B. Rodell
Kristen Shema
Krianthan Govender
Samantha E. Cassel

See next page for additional authors

Follow this and additional works at: https://tigerprints.clemson.edu/mecheng_pubs
Part of the Biomedical Engineering and Bioengineering Commons

Authors
Ellen Garver, Christopher B. Rodell, Kristen Shema, Krianthan Govender, Samantha E. Cassel, Bryan Ferrick,
Gabriella Kupsho, Ethan Kung, Kara L. Spiller, Randy Stevens, and Amy L. Throckmorton

ORIGINAL RESEARCH
published: 13 January 2022
doi: 10.3389/fbioe.2021.734310

Tunable Blood Shunt for Neonates
With Complex Congenital Heart
Defects
Ellen Garven 1, Christopher B. Rodell 2, Kristen Shema 1,3, Krianthan Govender 1,3,
Samantha E. Cassel 1,3, Bryan Ferrick 1,3, Gabriella Kupsho 1, Ethan Kung 4, Kara L. Spiller 3,
Randy Stevens 5,6 and Amy L. Throckmorton 1*
1
BioCirc Research Laboratory, School of Biomedical Engineering, Science, and Health Systems, Drexel University, Philadelphia,
PA, United States, 2Tissue Instructive Materials Laboratory, School of Biomedical Engineering, Science, and Health Systems,
Drexel University, Philadelphia, PA, United States, 3Biomaterials and Regenerative Medicine Laboratory, School of Biomedical
Engineering, Science, and Health Systems, Drexel University, Philadelphia, PA, United States, 4Department of Mechanical
Engineering and Bioengineering, Clemson University, Clemson, SC, United States, 5Pediatrics, College of Medicine, Drexel
University, Philadelphia, PA, United States, 6Heart Center for Children, St. Christopher’s Hospital for Children, Philadelphia, PA,
United States

Edited by:
Mingqiang Li,
Sun Yat-sen University, China
Reviewed by:
Nenad Filipovic,
University of Kragujevac, Serbia
Bing Jia,
Fudan University, China
*Correspondence:
Amy L. Throckmorton
Amy.Throckmorton@drexel.edu
Specialty section:
This article was submitted to
Biomaterials,
a section of the journal
Frontiers in Bioengineering and
Biotechnology
Received: 30 June 2021
Accepted: 17 November 2021
Published: 13 January 2022
Citation:
Garven E, Rodell CB, Shema K,
Govender K, Cassel SE, Ferrick B,
Kupsho G, Kung E, Spiller KL,
Stevens R and Throckmorton AL
(2022) Tunable Blood Shunt for
Neonates With Complex Congenital
Heart Defects.
Front. Bioeng. Biotechnol. 9:734310.
doi: 10.3389/fbioe.2021.734310

Despite advancements in procedures and patient care, mortality rates for neonatal
recipients of the Norwood procedure, a palliation for single ventricle congenital
malformations, remain high due to the use of a ﬁxed-diameter blood shunt. In this
study, a new geometrically tunable blood shunt was investigated to address limitations
of the current treatment paradigm (e.g., Modiﬁed Blalock-Taussig Shunt) by allowing for
controlled modulation of blood ﬂow through the shunt to accommodate physiological
changes due to the patient’s growth. First, mathematical and computational
cardiovascular models were established to investigate the hemodynamic requirements
of growing neonatal patients with shunts and to inform design criteria for shunt diameter
changes. Then, two stages of prototyping were performed to design, build and test
responsive hydrogel systems that facilitate tuning of the shunt diameter by adjusting the
hydrogel’s degree of crosslinking. We examined two mechanisms to drive crosslinking:
infusion of chemical crosslinking agents and near-UV photoinitiation. The growth model
showed that 15–18% increases in shunt diameter were required to accommodate growing
patients’ increasing blood ﬂow; similarly, the computational models demonstrated that
blood ﬂow magnitudes were in agreement with previous reports. These target levels of
diameter increases were achieved experimentally with model hydrogel systems. We also
veriﬁed that the photocrosslinkable hydrogel, composed of methacrylated dextran, was
contact-nonhemolytic. These results demonstrate proof-of-concept feasibility and reﬂect
the ﬁrst steps in the development of this novel blood shunt. A tunable shunt design offers a
new methodology to rebalance blood ﬂow in this vulnerable patient population during
growth and development.
Keywords: blood ﬂow, computational ﬂuid dynamics, biomaterials, hydrogels, pediatrics, single ventricle
physiology, shunt, congenital heart defects
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The current treatment (Figure 1) is a palliative, three-staged,
open-heart surgical sequence (Reller et al., 2008; Ohye et al.,
2010). In the ﬁrst stage, the Norwood procedure, the single
functional ventricle is connected to both the systemic and
pulmonary circulations via the implantation of a blood shunt,
which directs blood ﬂow into the pulmonary arteries from the
systemic circulation. The shunt remains in place for 3–6 months
until the second stage procedure (Ohye et al., 2010). There are
several shunt conﬁgurations; conventional procedures most
commonly use the Modiﬁed Blalock-Taussig shunt (MBTS,
Figure 2) conﬁguration, where the GORE® PROPATEN®
Vascular Graft conﬁgured for pediatrics is the preferred shunt.
It is comprised of an expanded polytetraﬂuoroethylene (ePTFE)
tube that is surface-modiﬁed by heparin to minimize
thrombogenicity.
Norwood patients require a delicate balance of blood ﬂow to
each of the parallel systemic and pulmonary circulations.

INTRODUCTION
Each year, approximately 4 million babies are born in the
United States, 1% of which have a congenital heart defect
requiring intervention (Oster et al., 2014; Mozaffarian et al.,
2015). A subset of these infants contend with substantial
structural anomalies characterized as single ventricle (SV)
physiology, such as tricuspid atresia or hypoplastic left heart
syndrome (HLHS). SV defects occur in approximately
1,000–2,000 live births annually (Reller et al., 2008). In
contrast to normal cardiovascular physiology with two
pumping chambers or ventricles, an SV physiology consists of
only one functional ventricle to drive and draw blood through
both the systemic and pulmonary circulations. This anatomy
results in limited perfusion, continual mixing of oxygenated and
deoxygenated blood within the SV, and 100% mortality without
surgical intervention.

FIGURE 1 | (A) The Norwood procedure with a Modiﬁed Blalock-Taussig shunt (MBTS) from the innominate into the right pulmonary artery (B) In the bidirectional
Glenn, the shunt is ligated and the superior vena cava is attached to the right pulmonary artery (C) The Fontan procedure attaches the inferior vena cava to the pulmonary
artery, creating the total cavopulmonary connection. The relevant anatomy includes the right pulmonary artery (RPA), right ventricle (RV), left ventricle (LV), left atrium (LA),
superior vena cava (SVC), and inferior vena cava (IVC).

FIGURE 2 | Overview of the Study. The Modiﬁed Blalock-Taussig shunt (MBTS) implanted in a single ventricle heart connects the systemic and pulmonary
circulations, with the relevant anatomy including the right pulmonary artery (RPA), right ventricle (RV), left ventricle (LV), left atrium (LA), left common carotid (LCC), and left
subclavian (LSA). We developed an infant growth mathematical model and computational cardiovascular model, which both informed the design requirements for the
proof-of-concept hydrogel prototype testing and then bio-orthogonal prototype testing with initial hemolytic standard experiments.
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FIGURE 3 | (A) Pulmonary blood ﬂow (Qp) model during growth and development; (B) 3D anatomical computational model was developed to include the
ascending aorta (AAo), descending aorta (DAo), innominate artery (IA), left common carotid (LCC), left subclavian (LSA), left pulmonary artery (LPA), and right pulmonary
artery (RPA); (C) The effect of diameter on the Qp/Qs ratio showed an increased amount of pulmonary ﬂow with larger diameters. (D) The effects of the viscoelastic model
are measured through the changes in viscosity at varying locations, the difference of which widens with respect to percent hematocrit.

Complications frequently result from instabilities in the systemicto-pulmonary blood ﬂow, either hyperperfusion or
hypoperfusion of the pulmonary arteries as delivered through
the shunt. A blood shunt diameter that is too narrow has an
increased internal resistance, which may lead to pulmonary
hypoperfusion, higher shear stresses, and irregular blood ﬂow
patterns that boost the risk of hemolysis and thrombosis. On the
contrary, a shunt that is too large draws more blood volume to the
lungs and away from the systemic circulation, adversely
impacting the oxygenation of systemic end organs. Thus, it is
critically important to select an appropriate shunt size to balance
ﬂow distribution.
While the shunt diameter is carefully chosen, many other
surgical and non-surgical factors can impact the balance of blood
ﬂow between the lungs and body. Shunt length and orientation,
vessel size, cardiac output, and pulmonary vascular resistance can
all alter the systemic-to-pulmonary blood ﬂow as the patient
develops. Clinicians manage the systemic-to-pulmonary blood
ﬂow balance using pharmacological therapies, percutaneous
interventions, or surgical correction. While pharmacological
management is routine, physical intervention (including
dilation, stent placement, or surgical correction) has been
reported in as many as 47.9% of MBTS cases between the
Norwood and Stage 2 surgergy (Ohye et al., 2010). Mortality
rates (7–19%) for the Norwood remain among the highest in
cardiac surgery and have not improved in decades despite
advancements in clinical procedures and patient care (Ohye
et al., 2010; Petrucci et al., 2011; Ohye et al., 2012). The high
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risk of complications and the lack of sustained improvements in
clinical outcomes highlight a fundamental ﬂaw in using a ﬁxed
diameter blood shunt. A shunt geometry that is speciﬁcally
designed to facilitate control over the balance of systemic-topulmonary blood ﬂow during developmental growth would be a
strong advance.
To address this unmet clinical need, we have developed a
geometrically tunable, hydrogel-lined conduit for use as a blood
shunt. This shunt was designed to have an expandable inner lumen
diameter that can be controllably modiﬁed in proportion to the
growth and development of the patient. Thus, this offers a new
approach to intrinsically adjust the ratio of systemic to pulmonary
blood ﬂow. The device design includes a ﬁxed-diameter outer sheath
coated internally with a thick hydrogel layer. Hydrogels are waterswollen polymer networks, known for their biocompatibility and
anti-fouling properties that make them ideal candidates for bloodcontacting biomaterials, such as catheters and shunts. Their degree of
crosslinking also directly controls hydrogel swelling, which means
that increasing the degree of crosslinking decreases swelling and
overall dimensions. Thus, we reasoned that a hydrogel lining of a
blood shunt would shrink as crosslinking is increased, resulting in an
overall wider inner lumen diameter if the other diameter is ﬁxed,
allowing the use of hydrogel crosslinking to control blood ﬂow. This
aspect of the hydrogel structure could be controlled by the infusion of
crosslinking agents or by near-UV photoinitiation.
In this study (Figure 2), mathematical and computational
ﬂuid dynamic (CFD) cardiovascular models (Figure 3) were
established to investigate the hemodynamic requirements of
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growing neonatal patients with shunts and to inform design
criteria for shunt diameter changes. Then, two stages of
prototyping were performed to design, build and test
responsive hydrogel systems that allow the shunt diameter to
be tuned according to the hydrogel’s degree of crosslinking. We
ﬁrst formed prototypes from a simple hydrogel system of gelatin
further crosslinked by glutaraldehyde, and we sought to explore
the feasibility of using hydrogel crosslinking to widen inner
lumen diameter while the outer diameter remained ﬁxed. In
the second set of hydrogel experiments, we employed more
biocompatible materials while also utilizing bio-orthoginal
photocrosslinking chemistries to enable eventual use within
the body. We fabricated these hydrogel prototypes using
methacrylated dextran (DexMA) hydrogels having various
degrees of methacrylate modiﬁcation, photocrosslinked in the
presence of a water-soluble and cytocompatible photoinitiator
(lithium phenyl-2,4,6-trimethyl-benzoyl-phosphinate; LAP) that
has broad absorbance including the near-UV range, which would
allow initiation of crosslinking in a patient via ﬁberoptic
illumination. All hydrogel prototypes were assessed for
dimensional changes over time. Finally, we tested the contact
hemolytic potential of methacrylated dextran-based hydrogel
according to ASTM standard F756-17. Static contact
experiments are critical ﬁrst steps in proof-of-concept studies
like these. These investigations demonstrate strong proof-ofconcept and lay the groundwork for the translational
development of this new tunable blood shunt.

To evaluate the hemodynamic effect of changes in the shunt
diameter, a model for CFD analysis was developed. Publicly
available MRI imaging data of a healthy adult were utilized
(Medical Connections Ltd., United Kingdom) and processed
into a three-dimensional model using Mimics (Materialize,
Leuven, Belgium). The anatomy of the aortic arch and
pulmonary artery was isolated and imported into Solidworks
(Dassault Systems, Waltham, Massachusetts, United States),
where the model was scaled to a neonatal size (body surface
area of 0.2 m2) based on typical dimensional data (Machii and
Becker, 1997; Dodge-Khatami et al., 2005; Garcia-Canadilla et al.,
2014; Park, 2014). An MBTS shunt was integrated between the
innominate artery and right pulmonary artery, the placement and
geometry of which was approved by an experienced pediatric
cardiothoracic surgeon.
ANSYS 15.0 CFX (ANSYS Inc., Canonsburg, PA,
United States) was employed to mesh the geometry
(Figure 3B). A mesh size of approximately 6 million elements
was developed after a grid independence study was conducted; a
range of grid densities monitored at several locations were
evaluated for <3% variation in velocities values and pressure
differentials. The mesh was further reﬁned to satisfy the
dimensionless wall distance (y+ < 1) requirement for the κ-ω
turbulence model, and to conﬁrm mesh quality metrics including
the skewness (max <0.95, average <0.33) and aspect ratio (max
<200, average <50). A parabolic velocity proﬁle using the
standard one-seventh power law was implemented as the
inﬂow boundary condition at the ascending aorta. The inlet
proﬁle was set to an average ﬂow rate of 0.9 L/min, which
reﬂects the average neonatal ventricular output before ductus
closure (Pekkan et al., 2008). Preliminary simulations were
conducted to determine effective pressures at the outlets
representative of the downstream resistances in steady state.
These outﬂow boundary conditions were set to obtain a
physiological distribution of ﬂow to each vessel, by matching
to reported average ﬂow splits (Lagana et al., 2005). All
simulations were conducted under steady-state conditions,
with a no-slip condition on all surfaces and a high-resolution
advection scheme. Convergence criteria were satisﬁed when the
maximum residual error reached less than 10–3.
Four shunt diameters were computationally evaluated (3.0,
3.5, 4.0, and 5.0 mm), corresponding to the range of available
clinical options per our surgical collaborator. For these studies,
blood was assumed to be Newtonian with a dynamic viscosity of
3.5 cP and density of 1,050 kg/m3. Although blood is known to be
non-Newtonian, it is often modeled to have Newtonian behavior
for shear rates greater than 100 s−1 (Al-Azawy et al., 2017).
To simulate the potential impact of “overgrowing” the shunt,
we created another geometry based on the inner lumen diameter
target. The identiﬁed target was implemented in a geometry based
on a percent increase from an initial diameter of 3.5 mm. This
geometry was simulated with a cardiac output proportional to the
ﬂow growth model (Figure 3A) and effective pressures that
preserved the targeted ﬂow distributions. These boundary
conditions were then applied to the 3.5 mm model to examine

MATERIALS AND METHODS
Growth Mathematical Model
In order to estimate a target dimensional change for the inner
lumen diameter of the tunable shunt, we had to establish an infant
growth model. To our knowledge, no such growth model for
Norwood recipients exists. We gathered available growth data
(Emmanouilides et al., 1995; Throckmorton et al., 2005),
especially measurement data of pulmonary blood ﬂow (Qp).
These data were ﬁt with a power law regression model
(Figure 3A), which allowed for the characterization of blood
ﬂow requirements for these patients over time (i.e. during
growth). Using the Hagen-Poiseuille model (Eq. 1) for blood
ﬂow in a tube, we estimated the range of inner lumen diameter
modulation that would be required to support infant growth and
development.
Q

r4 π(ΔP)
8μL

(1)

where r signiﬁes the radius, ΔP is the pressure drop across the
shunt, μ refers to the dynamic blood viscosity, L is the shunt
length, and Q is the blood ﬂow through the shunt (i.e., pulmonary
blood ﬂow, Qp). The power-law regression model was then set
equal to the Hagen-Poiseuille relationship (Eq. 1) so that we
could determine a range of viable shunt diameters. This enabled
us to set target requirements for the change in inner lumen
diameter over time in the hydrogel experiments.
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FIGURE 4 | Initial Gelatin Experiments. (A) A schematic of the mold with dowel used to gelate the prototype; The effect of glutaraldehyde concentration on the mean
inner diameter expansion, for concentrations of (B) control group without glutaraldehyde, (C) 0.05%, (D) 0.15%, (E) 0.25%, (F) 0.5%. (G) The diameter change
measured at the ﬁnal timepoint of each group is compared, all groups were found to be signiﬁcantly different than GC (*p < 0.05). Data are reported as mean ± s.d.

(PMMA) with an inner polytetraﬂuoroethylene (PTFE) dowel
that was placed in the center and formed the inner lumen of the
casing. The PMMA surface was chemically modiﬁed by
aminolysis with 1 M ethylenediamine-DMSO solution
(Brown et al., 2006). This added amine functional groups, to
ensure that the outer diameter of the hydrogel layer remained
ﬁxed to the PMMA ring following crosslinking. Gelatin (porcine
skin, type A) solutions were prepared between 4–12% weight/
volume (w/v), poured into the mold, and allowed to crosslink
during cooling. Then, the interior dowel was removed, resulting
in a hydrogel annulus (Figure 4A). We concentrated on the
inner diameter changes of the hydrogel prototypes for this
initial study; the axial length changes were not focused on
during this study. The ring thickness or axial depth averaged
approximately 1–2 cm.

the hemodynamics of a shunt left in place during physiological
changes due to growth.
In another diameter comparison, a multiscale model was
established and implemented, in which the boundaries of the
CFD model were coupled to a lumped parameter network (LPN)
of the Norwood physiology. The LPN uses an electrical analogy to
represent the ﬂuidic system in a set of ordinary differential
equations, the solution of which is approximated with a 4th
order Runge-Kutta method. The LPN and CFD models are
simulated in parallel; at every timestep, each model solves for
the pressures and ﬂows needed as boundary conditions in the
other model. The LPN was adapted from the work of Kung et al.,
and has a rich history of publication and validation (Kung et al.,
2013; Kung et al., 2014; Schmidt et al., 2017). This model was used
to recreate two diameters in the previous study, 3.0 and 3.5 mm,
the data of which will be compared to the CFD-only results for an
evaluation of the methodology.
We also evaluated the effect of a viscoelastic blood model, and
we assessed which regions were associated with low shear rates
and determined the suitability of the Newtonian assumption. A
viscoelastic blood model was implemented based on the work of
Good et al. (2016), with three hematocrits (20, 40, and 60%)
covering the full range expected clinically.
Simulation results were assessed qualitatively and quantitively.
Streamlines were inspected for vortices and eddies. The ratio of
pulmonary to systemic ﬂow (Qp/Qs) was calculated as a measure
of clinical success in balancing blood ﬂow. The average and
maximum velocities, shear rates, and shear stresses were
gathered for comparison. The diameter simulations were
compared against previous literature reports.

Effects of Crosslinking Density
Initially, the effect of crosslinker concentration on the inner diameter of
the prototype was evaluated (Figure 5). For proof-of-concept, we chose
gelatin-based hydrogels and the crosslinking agent glutaraldehyde
because these are readily available materials with well-characterized
interactions. The hydrogel was prepared using a 10% w/v gelatin
solution in phosphate-buffered saline (PBS) and was left to reach
equilibrium for 48 h. Then, to achieve increasing degrees of
crosslinking, the hydrogels were immersed in a bath of PBS and a
targeted concentration of glutaraldehyde, a known crosslinker of
gelatin at room temperature (Chatterji, 1989). The hydrogel
prototypes were treated by glutaraldehyde at varying concentrations
(0, 0.05, 0.15, 0.25, and 0.50%, n  6 per group) for 18 h. The effect of
the gelatin concentration was likewise evaluated. Hydrogels were
prepared using 4, 6, 8, and 12% w/v gelatin solutions and
submerged in glutaraldehyde solutions (0.05 and 0.50%, n  6 per
group). For all conditions, samples were photographed at regular time
intervals to capture the diameter changes.

Initial Gelatin Prototype
To construct the ﬁrst hydrogel prototype, a circular annular
(ring) mold was created using poly(methyl methacrylate)

Frontiers in Bioengineering and Biotechnology | www.frontiersin.org
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FIGURE 5 | (A) The effect of gelatin concentration on the mean inner diameter expansion, with 0.05% glutaraldehyde. (B) The effect of gelatin concentration on the
mean inner diameter expansion, with 0.50% glutaraldehyde. The effect of gelatin concentration on the inner diameter expansion as measured at the timepoint, for (C) the
0.05% glutaraldehyde and (D) the 0.50% glutaraldehyde samples. Mean ± s.d.; *p < 0.05.

Methacrylation of Dextran

Geometric Change Testing of Cylindrical
DexMA Hydrogels

Similar to the prior studies, solid cylindrical hydrogels were tested
for the ability to volumetrically change with response to
crosslinking as a lumen coating to a PMMA ring (Figure 6).
Photoinitiation was employed as the activation mechanism. The
second hydrogel prototype was fabricated by methacrylation of
dextran via glycidyl methacrylate (GMA) (van Dijk-Wolthuis
et al., 1995; Trappmann et al., 2017). A round bottom ﬂask was
charged with dextran (MW  70 kDa; 1.0 g) and 4dimethylaminopyridine (DMAP; 0.2 g), stoppered, and purged
by anhydrous nitrogen. Anhydrous DMSO (Sigma-Aldrich) was
added via cannulation to a ﬁnal concentration of 5% w/v dextran.
After dissolution, glycidyl methacrylate (GMA) was injected via
syringe and the reaction was carried out in the dark for 72 h at
45°C with stirring. The solution was dialyzed (Slide-A-Lyzer G2
Dialysis Cassettes, gamma-irradiated, 10 K molecular weight
cutoff, Fisher Scientiﬁc) for 14 days against deionized water
with dialysis media change twice a day. The DexMA solution
was lyophilized until dry and stored at −20°C until use. To
prepare different degrees of methacrylation (% of polymer
repeat units modiﬁed), the ratio of added GMA to dextran
was varied (93.0, 465.1, or 883.7 µl GMA). Three different
degrees of methacrylated DexMA were achieved: 10% DexMA,
50% DexMA, and 95% DexMA.

Frontiers in Bioengineering and Biotechnology | www.frontiersin.org

Hydrogels of 10% DexMA, 50% DexMA and 95% DexMA were
prepared from 10% w/v polymer solutions containing 0.25% w/v
LAP (Sigma-Aldrich). Hydrogels (n  3 per group) were
photocrosslinked using a near-UV light (3D Printer UV Resin
Curing Light, 405 nm, 6 W output) for 3.5 min and swollen to
equilibrium in PBS, removing residual LAP. They were then
moved into fresh 0.25% w/v LAP solution, subjected to
photocrosslinking using the same light source, and the overall
changes in volume and diameter were quantiﬁed over 10 min of
light exposure. MATLAB image analysis was used to quantify the
change in diameter, and to determine if the rate of diameter
change was inﬂuenced by the degree of methacrylation. The
volumetric change was quantiﬁed by digital caliper
measurements of height and diameter pre- and post-crosslinking.

Fabrication of DexMA Prototype
To afﬁx the prepared DexMA to annular PMMA tubing, serving as
the outer layer of the device, unmodiﬁed PMMA underwent surface
plasma oxidation (1 min, PDC-32G Plasma Cleaner), followed by
immediate submersion in excess methacrylic anhydride for 10 min to
introduce free methacrylate groups to the surface of the PMMA
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FIGURE 6 | (A) A schematic of the PMMA tubing functionalization process and DexMA prototype fabrication of a rigid PMMA outer layer ﬁlled with DexMA hydrogel
with 3.5 mm circular punch extracted from the center. (B) Volume comparison before (Pre) and after (Post) 10 min of near-UV crosslinking of DexMA gels (n  3; mean ±
s.d.; ***p < 0.001). 95% DexMA demonstrated largest volume change (C) Diameter change upon UV-crosslinking of DexMA gels based on image capture analysis in
MATLAB (D) Temporal dependence of diameter change upon near-UV crosslinking of DexMA gels based on image capture analysis in MATLAB (mean ± s.d.). after
10 min of near-UV exposure. A 15–18% change in lumen diameter, necessary for physiologically relevant changes in ﬂow, is indicated.

tubing. After washing, the methacrylated PMMA was ﬁlled with
DexMA and LAP solution (10% w/v DexMA; 0.25% w/v LAP) and
photocrosslinked for 3.5 min. The center was then extracted using a
3.5 mm biopsy punch, and the device was swollen to equilibrium
in PBS.

in contact with rabbit blood. Material extracts were prepared as
speciﬁed in ASTM F619: Practice for Extraction of Medical
Plastics. Relative to a positive (Buna-N-Rubber) and negative
(Low-Density Polyethylene) control plastic material, the
hemolytic activity of 95% DexMA (10% w/v) hydrogels was
assessed and reported as speciﬁed. Figure 7 illustrates this
process.

Geometric Change Testing of DexMA
Prototype

Diameter Dimensional Analysis

Geometric change testing of the DexMA prototype was carried
out with the optimally methacrylated 95% DexMA hydrogel,
which was determined through the geometric change testing of
cylindrical DexMA hydrogels. After swelling the prototype to
equilibrium for 24 h, another photocrosslinking event was
carried out with the same near-UV light source for 10 min
immediately after re-submersion in a 0.25% w/v LAP solution
to assess the geometric change that occurred during near-UV
exposure. The lumen expansion was quantitatively assessed by
processing images taken before and after exposure using
MATLAB. The outer diameter change was quantitatively
assessed in the same manner to ensure that no separation
from the PMMA outer layer occurred. A plot of inner and
outer diameter change over time was generated and a linear
regression was ﬁt to each set of data.

To facilitate ease of fabrication, the dimensions of the gelatin
prototype were larger than the shunt diameters used clinically
(i.e., prototype outer diameter of 10 mm versus clinical shunt
diameter of 3.5 mm). To compare the diameter change of the
hydrogel prototype to the expected diameter change of an
implantable shunt, a scaling relationship based on the volume
was developed. Since the amount of crosslinking depends directly
on the number of functional groups, the volume change between
the test prototype and a theoretical implantable shunt crosssection would be the same, if the hydrogel composition does not
change. Therefore, in Eq. 2, the inner diameter of the theoretical
implantable shunt after crosslinking de,t, was related to the
starting inner diameter of the theoretical shunt, ds,t, and the
starting and ending inner diameters of the test prototype, ds,p
and de,p:

(2)
de,t  ds,t 2 + de,p 2 − ds,p 2

Material-Induced Hemolysis Testing
The material-induced hemolysis of 95% DexMA was tested
according to ASTM F756-17: Standard Practice for Assessment
of Hemolytic Properties of Materials. The objective is to evaluate
the acute hemolytic properties of the DexMA prototype when it is

Frontiers in Bioengineering and Biotechnology | www.frontiersin.org

This relationship was used to quantify the percent change in the
theoretical implantable shunt in Eq. 3 based on the measured
changes in diameters of the prototype:
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FIGURE 7 | (A) Schematic of sample preparation for hemolytic tests. (B) Percent hemolysis of sample extracts, background subtracted relative to PBS (n  3;
mean ± s.d.; ***p < 0.001). (C) Schematic of hemolysis testing procedure. (D) Percent hemolysis of direct contact samples, background subtracted relative to PBS (n  3;
mean ± s.d.; ***p < 0.001).

Δdt 


ds,t 2 + de,p 2 − ds,p 2 − ds,t
ds,t

× 100

pulmonary to systemic blood ﬂow, such that Qp/Qs ≤ 1.5 (Barnea
et al., 1994; Austin, 1998). The cardiac outputs of healthy infants
between birth and 2 years of age were used (Emmanouilides et al.,
1995; Throckmorton et al., 2005). The necessary shunt ﬂow rates,
Qp, were then calculated to maintain the chosen Qp/Qs ratio of
0.9 for Norwood patients, and the results of which were modeled
as a power-law function (Figure 3A) with respect to age (time in
days) in Eq. 4:

(3)

Image Processing
Images of the gelatin samples were acquired using a 12-megapixel
camera with a 5X digital zoom and were recorded at a ﬁxed
distance. A 2D high pass Gaussian ﬁlter was used to ﬁlter the
images before processing using MATLAB (R2016b, Mathworks,
Natick, MA, United States). Changes in inner lumen diameter
after exposure to the crosslinking solution were measured.

QP (t)  0.351t0.118

Using the power law regression and Hagen-Poiseuille
relationship, we identiﬁed the requirement that the inner
lumen diameter should expand by 15–18% (midpoint of
16.5%). This was used for the computational modeling and
hydrogel experiments.

Statistical Analysis
Results are reported as the percent change (mean ± standard
deviation); signiﬁcance was determined by one-way analysis of
variance (ANOVA) with Tukey-Kramer post-hoc testing for
between group comparisons (p < 0.05). For paired samples
before and after crosslinking, signiﬁcance was assessed by
paired two-tailed T-test assuming equal variance (p < 0.05).

Simulation Findings
Building upon the growth model, we analyzed an anatomical and
computational model that was created of the shunt and Norwood
physiology. In the development of this, a grid-independence
study was conducted to select a mesh density that maintained
the accuracy of the solution while balancing the overall
simulation time. Steps were taken to ensure a high-quality
mesh (y+satisﬁed), including reﬁnements to satisfy the criteria
of the dimensionless wall distance, the skewness, and the aspect
ratio. The ﬁnal model geometry consisted of approximately
6 million tetrahedral elements.
In these CFD studies, increasing inner lumen diameter was
shown to increase the pulmonary-to-systemic ﬂow (Qp/Qs) ratio,

RESULTS
Growth Model Informs Shunt Design
To inform target design requirements, we theoretically
determined a range of acceptable inner lumen diameter
changes for Norwood recipients as a function of growth
during shunt usage. For an ideal shunt diameter, the target
clinical measure of success is to maintain a constant ratio of
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FIGURE 8 | (A) Schematic of the multiscale model, the LPN is simpliﬁed for illustrative purposes; (B) The effect of diameter on the Qp/Qs ratio was reproduced for
two datapoints using the multiscale model and showed similar results compared to the CFD-only approach.

as expected, because the larger lumen diameter decreased the
resistance of the shunt and allowed for more pulmonary ﬂow. The
ﬂow ratios were found to vary between 0.6–2.6, increasing with
shunt diameter (Figure 3C). The Qp/Qs ratio of the baseline
model was veriﬁed to be 0.8 for the 3.5 mm shunt, reﬂecting
distributions observed in Norwood recipients (Barnea et al.,
1994).
Based on a midpoint (16.5%) of the 15–18% change range
identiﬁed, a 4.08 mm model geometry was created to represent a
16.5% increase from the 3.5 mm size often used clinically. The
conditions of the 4.08 mm model were applied to the 3.5 mm
model to simulate the impact of growth while using a ﬁxed shunt,
the results of which showed that the Qp/Qs ratio decreased to
0.57; systemic ﬂow dominated due to the increased cardiac output
and the resistance of the narrow shunt. Higher velocities and
larger regions of recirculation were found within the shunt, and
more disturbed blood ﬂow patterns were found in the pulmonary
and innominate arteries.
The multiscale model (Figure 8A) was implemented for two
diameters, 3.0 and 3.5 mm. Similar to the CFD-only approach,
the parameters of the LPN were tuned to the 3.5 mm diameter
and then applied to the other diameter. The resulting Qp/Qs
ratios (Figure 8B) were similar to the CFD-only model and
magnitudes reported in literature.
The viscoelastic blood behavior was observed through
differences in the dynamic viscosity at various locations in the
geometry. Shear strain rates below 100 s−1 were observed in
regions of the ﬂuid domain of the model. However, the
entirety of the shunt was above that threshold at each
hematocrit. Consequently, the dynamic viscosity was higher at
the aortic inlet than in the shunt (Figure 3D). This difference was
more pronounced at higher hematocrits.

excluded from the analysis. All intact samples exposed to the
crosslinking agent, glutaraldehyde, were observed to
asymptotically increase in inner lumen diameter over the time
of crosslinking, in contrast to the control group which decreased
by 24 ± 5.0% due to swelling (Figures 4B–G). The rate at which
the diameter changed varied between the groups. At the ﬁnal
timepoint (18 h), there were no signiﬁcant differences observed
between the crosslinked groups. The largest percent change was
16.5 ± 5.0%, in the 0.25% glutaraldehyde condition; however, the
majority of the samples had a diameter change below the design
target of 15–18%. Crosslinking processes had minimal effect on
the outer diameter of the construct, averaging less than 0.25%.
The maximum recorded change in outer diameter across all
conditions was less than 1.0%, consistent with error of the
image analysis methods.

Effect of Gelatin Concentration on Inner
Diameter
The effect of the gelatin concentration on the change in inner
lumen diameter was assessed at two glutaraldehyde
concentrations.
Across
both
of
these
crosslinker
concentrations, increasing gelatin concentration reduced the
magnitude of the change in diameter. In the 0.05%
glutaraldehyde group, the 12% gelatin sample swelled,
resulting in a nearly 10% reduction in lumen diameter
(Figure 5A). The largest inner lumen diameter changes
occurred at 4% w/v gelatin in 0.5% glutaraldehyde, with a
diameter expansion of greater than 20% (Figure 5B). The 4
and 6% gelatin samples contracted and reached the target
diameter change of 15–18% in the 0.5% glutaraldehyde group.
At the lower glutaraldehyde concentration, only the 4% gelatin
reached the target. Final changes in diameter were highly
dependent on gelatin concentration (Figures 5C,D). In the
0.05% glutaraldehyde group, all gelatin concentrations were
found to differ signiﬁcantly from one another. For the 0.5%
glutaraldehyde case, signiﬁcant differences were observed except
between the 6 and 8% gelatin (p  0.42), and 8 and 12% gelatin
(p  0.21).

Effect of Crosslinker on Inner Diameter
Expansion
The ﬁrst experiment assessed the effect of the crosslinker
concentration on the inner lumen diameter expansion of the
hydrogel. Samples that were damaged during preparation were
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Effect of Methacrylated Dextran
Concentration

DISCUSSION
This study demonstrates the proof-of-concept that increasing
crosslinking can be used to expand the diameter of hydrogel-lined
shunts, with hemodynamic advantages compared to ﬁxeddiameter shunt designs. These results provide the foundation
for the development of feasible translational designs, including
those with biomaterials and crosslinking agents that are safe for
use in the human body [e.g., synthetic, neutral polymers
crosslinked with bio-orthogonal chemistries (DeForest and
Anseth, 2011)] and that can be delivered to the hydrogels by
non- or minimally-invasive techniques (i.e., through the
bloodstream or by release from within a delivery system
contained within the hydrogel).
The design of a geometrically tunable blood shunt offers
several advantages over products currently available or under
investigation. Previously, researchers have attempted to address
these limitations with various designs, including modiﬁcations
relying on the mechanical constriction of the shunt through
external plungers, balloons, ductal stenting, or clips (Douglas
et al., 2010; Motohashi et al., 2018; Murtuza et al., 2012). These
designs lack the ability to modify the diameter uniformly, which
could increase the risk of thrombus formation. Moreover, these
strategies rely on heavily invasive techniques or external
equipment, which complicate their use as a durable
intervention. In contrast, hydrogels crosslink relatively
uniformly, and the degree of crosslinking could be controlled
using minimally-invasively techniques. Additionally, previous
designs have relied on data from clinical and animal studies,
both of which were limited in sample sizes, and primarily
neglected computational analysis despite its proven value and
growing popularity in patient-speciﬁc modeling and surgical
planning (Biglino et al., 2013; Arthurs et al., 2017).
In recognition of the clinical beneﬁts of a dilatable shunt for
Norwood patients, a new expandable polytetraﬂuoroethylene
vascular conduit (PECA Labs, Inc., Pittsburgh, PA) is now
available (Loneker et al., 2017; Loneker et al., 2018; Qadir
et al., 2020). This device can be radially modulated via
percutaneous balloon dilation and employs an expandable
PTFE material of construction. Developers have demonstrated
maintenance of mechanical properties post-expansion and
achievement
of
nonhemolytic,
nonpyrogenic,
and
noncytotoxic. In constract, we seek to advance our conduit
design one step further by using external activation methods
to trigger inner lumen expansion, and we are concentrating on
the biomaterial chemistry and functionality in these early phase
experiments.
For the repair of congenital heart defects, a number of
researchers have investigated the use of tissue-engineered
vascular grafts (Drews et al., 2017; Best et al., 2018). These
materials were designed speciﬁcally to address the growth
potential of the grafts, by replacing the artiﬁcial material used
currently with a scaffold seeded to grow native tissue in its place.
For the Norwood, previous studies determined that artiﬁcial
grafts offered greater success in comparison to using
neighboring native vessels in place of the shunt (de Leval
et al., 1981; Ullom et al., 1987). These ﬁndings suggest that

Following proof-of-concept experiments with gelatin
hydrogels crosslinked with glutaraldehyde, we next prepared
hydrogels crosslinked with more biocompatible methods.
Methacrylated dextran hydrogels were prepared and
crosslinking was initiated by LAP in the presence of nearUV light. In these experiments, some degree of chemical
crosslinking was required prior to initiation of the
experiments, since dextran hydrogels do not crosslink
physically as gelatin hydrogels do. Further increasing
crosslinking via subsequent exposure to near-UV light for
10 min further decreased hydrogel volume.
A decrease in hydrogel volume was observed throughout
additional near-UV exposure conducted immediately after
submersion in the photoinitiator solution, dependent on the
degree of methacrylation (Figure 6B). The volumetric
decrease was 14.8% for the 10% DexMA, 22.1% for the 50%
DexMA, and 30.5% for the 95% DexMA; all of which were
signiﬁcant changes from pre-exposure measurements.
Interestingly, increasing methacrylation did not affect the
rate of volumetric change. The slopes remained similar
among data sets (0.07, 0.08, and 0.1 mm/min, respectively),
but the intercept values were signiﬁcantly different (i.e., initial
hydrogel diameter) between each condition, reﬂective of
different equilibrium swelling ratios prior to light exposure
(Figure 6C).

Effect of UV Exposure Time
Based on the results of this experiment and theoretical
considerations, 95% DexMA was selected as the optimal
formulation for continued investigation. It exhibited the
largest decrease in volume upon light exposure, and should
therefore allow for the greatest modulation of the shunt
geometry. The 95% DexMA was therefore used for ﬁnal
prototype construction and evaluation of changes in lumen
diameter. When evaluating the effects of light exposure time,
the required 15–18% increase in lumen diameter was achieved in
approximately 5 min of exposure using the 95% DexMA
(Figure 6D), with a less than 1% change in the outer diameter
of the prototype construct.

First Test: Static Hemolytic Evaluation
Finally, we conducted an initial evaluation of the
hemocompatibility of the dextran-based hydrogels
according to ASTM F756-17, which measures hemolysis in
the presence of extracts from the biomaterials or in direct
contact with blood, using Buna N Rubber as a positive control.
Extracts from the 95% DexMA hydrogels showed hemolytic
activity comparable to negative controls (LDPE), having a
hemolytic index of 1.263 (Figure 7B). In examination of
direct blood contact, 95% DexMA had 30% of the
hemolytic activity of LDPE (Figure 7D). This corresponds
to a hemolytic index of 0.154 (nonhemolytic by direct contact
test). This material is therefore suitable for blood-contacting
indications, as speciﬁed by ASTM F756-17.
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native vessel growth may not be reﬂective of the necessary
hemodynamic changes in this unique anatomy; indicating that
sizing of a tissue-engineered graft would also present challenges.
While using tissue engineering to develop a healthy blood vessel
from the patient’s own cells is attractive, these designs face
substantial clinical and translational hurdles because of
challenges in cell source and development of mechanical and
hemodynamically functional grafts on the timescales demanded
for the Norwood procedure, as well as in the manufacturing and
commercialization potential of individualized grafts.

and Laín (2015) found that the Newtonian assumption was
sufﬁcient for conditions with higher velocities, which
supported the use of the Newtonian assumption in regions
like the aortic arch. However, the regions of low shear rates
observed in this model indicated that the assumption may not be
reasonable. Despite the region of the shunt satisfying the
Newtonian criteria, the upstream effects of low shear strain
rates may alter the ﬂuid behavior in the shunt.
Computational limitations should be noted. First, the diameter
study was conducted with no other changes to the parameters of
the model. Future studies should incorporate changes that may
occur due to patient growth including changes in vessel shape or
ﬂuid conditions. In addition, we approximated outlet boundary
conditions by applying effective pressures to achieve
physiologically relevant ﬂuid distributions, neglecting
downstream peripheral resistance. This simpliﬁcation was
adequate for our initial comparative purposes done in steady
state; however, it does limit the range of the analysis. The
multiscale methodology addresses many of these limitations
and will be utilized in future investigations that require more
advanced modeling techniques. The viscoelastic blood model was
implemented based on the work of Good et al. at only three
distinct hematocrits, which constraints the range and ability of
our analysis. There is no singular model of blood behavior used in
the ﬁeld; this is one of several models that could have been
utilized. Other popular models, which have been used to describe
arterial ﬂow, include the Carreau model, the Casson model, and
the Power Law model (Cho and Kensey, 1991; Johnston et al.,
2004; Boyd et al., 2007). These limitations, notwithstanding, the
computational models demonstrate proof-of-concept that a
blood shunt with a controllable inner lumen diameter would
be beneﬁcial for patients undergoing the Norwood procedure.
While these computational ﬁndings demonstrate the critical
importance of physiologically relevant boundary conditions in
the modeling of these blood ﬂow dynamics, the results supported
hydrogel prototyping using the 15–18% target requirement and
indicate the need for a multiphysics computational platform for
this cardiovascular physiology.

Computational Analysis
In the computational studies, the Qp/Qs ratios in the shunt
diameter study were found to agree with the relationships and
magnitudes widely reported. As the diameter of the shunt
increased, the pulmonary ﬂow increased and therefore the Qp/
Qs ratio increased. This behavior was expected given the ﬂuid
physics, because larger diameters have less internal resistance and
therefore greater ﬂow rates. The computational results of this
study were compared with a lumped parameter model utilized in
a number of published studies by Migliavacca et al. (2001).
Despite the differences in approach between this study and
Migliavacca et al. (2001), the recorded effect on the Qp/Qs
ratio and the magnitudes of the ratio itself were in agreement,
demonstrating the fundamental ability of our model to predict
the hemodynamics.
Of particular interest was the effect of a 3.5–4.08 mm
diameter change, which represents the speciﬁed hydrogel
design requirements (15–18% increase). These results
suggest that the consequences of the patient “overgrowing”
the shunt include limited pulmonary ﬂow, as well as increased
regions of recirculation and other low-velocity regions, which
are known to have higher thrombogenic potential (Celestin
et al., 2015). These studies demonstrated the marked
hemodynamic differences caused by minor geometric
changes, and illustrated one of the current clinical
limitations, in which even the smallest discrete diameter
choices available to clinicians resulted in wide
hemodynamic changes. These wide hemodynamic changes
may translate into clinical consequences and poor outcomes.
The multiscale modeling effort represents the direction and
intention of the next stage of computational analysis in this
project. This methodology captures elements unable to be
represented in CFD alone and broadens the scope of possible
investigations. These techniques will be fully implemented in
future work; the results of which will provide deeper insight into
how the tunable shunt could function within the Norwood
physiology.
The studies demonstrated that a viscoelastic blood model was
successfully implemented based on the work of Good et al.
(2016). There was a discrepancy in the viscosity recorded at
different locations within the geometry, which is indicative of the
low shear strain rates observed in the aorta. This effect was made
more dramatic as the hematocrit increased, as the higher
hematocrits resulted in larger viscoelastic effects. These results
demonstrated the shear-thinning nature of the ﬂuid model. In a
comparison of different blood models within the aorta, Caballero
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Hydrogel Prototype Development
The results of the biomaterials experiments demonstrated that
changing polymer concentration and degree of crosslinking
allowed control over lumen expansion to a degree that met
the speciﬁed design requirements. The inner diameter
expansion was studied under the effect of varying
glutaraldehyde and gelatin concentrations. In the experiment
investigating the effects of glutaraldehyde concentrations,
higher concentrations were not statistically associated with
more expansion and therefore greater amounts of crosslinking.
During the period of initial exposure, higher glutaraldehyde
concentrations were observed to crosslink at an increased rate,
due to the initial diffusion of the crosslinker. Researchers have
reported that the amount of crosslinking ampliﬁes with
increasing concentrations of glutaraldehyde, up to 1% (Bigi
et al., 2001). However, it was also reported that 0.05%
glutaraldehyde is sufﬁcient to crosslink approximately 60% of
the available groups.
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The experimental results investigating the effects of gelatin
concentrations indicated that the inner diameter expansion
design requirements were achievable with lower gelatin
concentrations. Hindered hydrogel contraction at increasing
gelatin concentrations may be the result of polymer hydration
and polymer-polymer resulsion that counter crosslink-driven
deswelling. The design requirement was satisﬁed with a 0.5%
glutaraldehyde concentration with both 4 and 6% w/v gelatin
solutions, and with 0.05% glutaraldehyde with 4% w/v gelatin
solutions (Figures 5, 6). While the application of
glutaraldehyde crosslinking in vivo is limited by toxicity
concerns and cross-reactivity with abundant amines in
biological ﬂuids and tissues, these studies provided evidence
for the ability of tunable crosslinking approaches to achieve
lumen expansion while preserving the outer diameter of the
prototype.
The second prototype incorporated photocrosslinkable
polymers and a potentially translational method of
crosslinking via light exposure. Here, we selected
methacrylated dextran (DexMA) as a base material, owing
to the well-established cytocompatibility of these polymers,
including the soluable form (ref) and throughout crosslinkg in
the pressure of cells (ref). The Phase II hydrogel prototype
achieved a physiologically relevant lumen diameter increase
within minutes of near-UV exposure. The device is therefore
capable of achieving the dimensional changes needed to
support patient growth while remaining afﬁxed to the outer
layer. Furthermore, DexMA is nonhemolytic under ASTM
F756-17 and is suitable for the blood-contacting indication
that this design addresses. LAP is a non-toxic and watersoluble photoinitiator with a broad activation spectrum
spanning the UV and near-UV range (Fairbanks et al.,
2009), which could be used to achieve crosslinking in a
methacrylated hydrogel in vivo. Though, the methods by
which the photoinitiator is introduced into the hydrogel
lumen may require ongoing reﬁnement. Studies here have
demonstrated that additional photocrosslinking is possible
immediately after introduction of LAP in a static
environment. Outcomes are likely the result of rapid LAP
diffusion, owing to the high degree of water solubility, in
combination with radical diffusion mediated by both
physical and chemical processes (Colvin et al., 1997;
Higgins et al., 2020). Given the permissive route for
photoinitiator
introduction,
percutaneous
catheter
placement inside of the shunt could feasibly be used to
introduce soluble LAP concurrent with exposure to nearUV light via a ﬁber-optic light guide. These methods,
however, necessitate ongoing development of suitable light
guide assemblied to perform the procedure and investigation
of the methods under ﬂow that better reﬂects in vivo
conditions.
Static blood-contact hemocompatibility studies were
performed on the DexMA shunt prototype. The rationale for
this static evaluation stems from these studies being a reasonable
ﬁrst step evaluation in the efﬁcacy of using DexMA for this
application. We recognize the importance of experiments under
more physiologic and shear ﬂow conditions. It is important to
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assess how well these hydrogels will retain their structure,
function and stability during blood ﬂow conditions. Shunt
thrombosis is of high occurrence in the currently used shunts,
thus is a demonstrated mortality and morbidity risk for these
patients. This new hydrogel-lined conduit must incorporate
material properties that mitigate platelet adhesion and triggers
leading to coagulation. These will be a priority in forthcoming
investigations.
Limitations in manufacturing techniques must also be
considered as we plan to construct these shunts with longer
lengths. General clinical translation of this approach requires
the development of responsive hydrogel systems that are
compatible with the blood-contacting environment and
which leverage bio-orthogonal crosslinking chemistries. As
a blood-contacting biomaterial, the shunt should also be
subjected to rigorous hemocompatibility testing, including
for toxicity and thrombogenicity in the next phase of
development.

CONCLUSION
A novel tunable shunt design offers a new treatment paradigm
to rebalance blood ﬂow in neonatal patients who receive the
complex Norwood procedure and who seek cardiophysiologic
stabilization that accompanies growth and development postoperatively. The experimental and computational results of
this investigation have demonstrated proof-of-concept and
feasibility in the design of a geometrically tunable hydrogelbased shunt. The growth model and computational
cardiovascular studies informed the design requirement for
the inner lumen diameter change (15–18%) and revealed the
importance of physiologically relevant boundary conditions
in the modeling of these blood ﬂuid dynamics. The hydrogel
experimental results tested and demonstrated achievement of
the target design requirement for inner lumen diameter
change. The satisfaction of this requirement is a positive
indicator of the design feasibility going forward. DexMA is
nonhemolytic under ASTM F756-17 and is suitable for the
blood-contacting indication that this device treats. Taken
together these studies are parallel and complementary
endeavors that demonstrated the feasibility of a new
device design and advanced the development effort of an
innovative geometrically tunable blood shunt for Norwood
recipients.
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